in Search

Adverse Reactions

It gets nasty for Nice

For such a haven of faceless bureaucrats, NICE has suddenly become the hate figure of the UK.  NICE - or the National Institute for Health and Clinical Excellence - is the gatekeeper of the National Health Service, and it is the ultimate arbiter of the drugs that are prescribed by doctors.

Sometimes drugs are turned down on grounds of cost, sometimes because they just don't work.  For the drug company, a rejection is nothing less than a commercial disaster, especially if the drug concerned is a pioneering one that would have cost at least £150m to get approved.

The patient, too, may see the drug as the great hope.  It happened with the *** cancer drug Herceptin, and it's happening again with the Alzheimer's drug Aricept.  If the drug is the 'answer', then NICE's rejection is nothing less than a callous disregard of human life.

Alzheimer's sufferers and their carers are planning a major protest against NICE's decision with nationwide marches and demonstrations.  The same thing happened with Herceptin, and the government finally wilted to public demand.

In the case of Aricept, the protestors are being joined by the manufacturer, Pfizer, which is calling for a judicial review of NICE's rejection.  If it goes ahead, it will be the first time that NICE has been challenged in court, and itvmay well not be the last.

But how does the patient know that the drug is the solution to his or her ills?  In the case of Aricept, there are a few anecdotal reports that the drug has helped, but a major review that was published in 2004 concluded that it wasn't providing any benefits, even to the early-stage patient.

A similar story can be told about Herceptin.  Many of the protests were encouraged by the drug manufacturer which eventually got its way.

Will the same happen with Aricept? You betcha it will.

 


Click here for related WDDTY content 

Comment Notification

If you would like to receive an email when updates are made to this post, please register here

Subscribe to this post's comments using RSS

Comments

 

dgtucker said:

Money, money, money....as ever! NICE is right in these cases.

The drug companies are extremely adept at marketing dangerous products and know how to whip up public hysteria for their hyped up junk.

September 25, 2007 17:47
 

Harradine said:

As came out in the indepedant judicial review evidence (unless you are now also suggesting that the UK Judiciary is controlled by Esai?), Arciept is an effective drug for early stage Alzheimer's.  Sadly it is not a cure, there is so far no such thing.  But it does slow the prgroess of cognitive defects that are hallmarks of the early stages of the disease.

I'm not clear on where you stand on this issue.  Are you saying that NICE was wrong to advise that Aricept should be used?  Or are you saying that aricept is of no benefit and therefore NICE were correct?  There seems to be some contradiction in your argument, or at least in how you present them.

November 5, 2007 23:22

Leave a Comment

(required) 
(optional)
(required) 
Submit

This Blog

Syndication

News

FREE REPORT: Discover 100 ways to live to be 100 This special report includes 100 great tips to help you live longer and healthier – right up to the age of 100. This report is available for download right now – and it’s free. Click here to claim your copy.
Terms and conditions | Advertise | About us | Contact us

(C) 2006 Copyright Conatus plc. All Rights Reserved.